Does BOTULINUM TOXIN TYPE A Cause Atrioventricular septal defect? 9 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Atrioventricular septal defect have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 0.2% of all adverse event reports for BOTULINUM TOXIN TYPE A.
9
Reports of Atrioventricular septal defect with BOTULINUM TOXIN TYPE A
0.2%
of all BOTULINUM TOXIN TYPE A reports
0
Deaths
9
Hospitalizations
How Dangerous Is Atrioventricular septal defect From BOTULINUM TOXIN TYPE A?
Of the 9 reports, 9 (100.0%) required hospitalization.
Is Atrioventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Atrioventricular septal defect?
RITONAVIR (29)
LAMIVUDINE (25)
EMTRICITABINE\TENOFOVIR DISOPROXIL (24)
ONDANSETRON (24)
NEVIRAPINE (22)
ABACAVIR (21)
ALPRAZOLAM (21)
ASPIRIN (21)
DIAZEPAM (21)
LAMIVUDINE\ZIDOVUDINE (21)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Atrioventricular septal defect Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE